# Etomidate

NDC: 0143-9311
Generic name: Etomidate
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20160225

FDA application: ANDA202354

## Active ingredients

- ETOMIDATE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0143-9311"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0143-9311
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4312e3c3-34de-4cb3-8abd-c24d24a4bea1